维普期刊资源整合服务平台（V6.5）

59篇 您的检索式：作者名="Reguart"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung patients treated with induction and consolidation chemotherapy : feasibility and activity results 显示文摘	Reguart N Vinolas N Casas F	2004	Lung Cancer2004，45，1：	1
2	Beyond EGFR TKI in EGFR-mutant non-small cell lung cancer patients: Main challenges still to be overcome 显示文摘	Remon J Moran T Reguart N	2014	Cancer Treat Rev2014，40，6：	1
3	BRCAI: A new genomic marker for non-small-cell lung cancer 显示文摘	Reguart N Cardona AF Carrasco E	2008	Clin Lung Cancer2008，9，6：	1
4	The role of Wnt signaling in cancer and stem cells显示文摘	Reguart N He B Taron M	2005	Future Oncol2005，1，：	1
5	Epidermal growth factor recaptor activation:How exonl9 and21 mutations changed our understanding of the pathway显示文摘	Resell R Taron M Reguart N	2006	Clin Cancer Res2006，12，24：	1
6	Epidermal growth factor receptor activation:how exon 19 and 21 mutations changed our understanding of the pathway显示文摘	Rosell R Taron M Reguart N	2006	Clin Cancer Res2006，12，24：	1
7	XPD polymorphisms in cisplatin (cis)/vinorelbine (vrb) -treated stage Ⅳ non -smallcell lung cancer (NSCLC) patients (p):genetic analysis of a Spanish Lung Cancer Group phase Ⅱ trial显示文摘	Vinolas N Roig B Reguart N	2003	Lung Cancer2003，41，2：	1
8	Cloning and characterization of the promoter of human wnt inhibitory factor-1显示文摘	Reguart N He B Xu Z	2004	Biochem Biophys Res Commun2004，323，1：	1
9	Epidermal growth factor receptor activation:how exon 19 and 21 mutations changed our understanding of the pathway显示文摘	Rosell R Taron M Reguart N	2006	Clin Cancer Res2006，12，24：	1
10	Determining the appropriate sleeve lobectomy versus pneumonectomy ratio in central non-small cell lung cancer patients:an audit of an aggressive policy of pneumonectomy avoidance显示文摘	Gómez-Caro A Garcia S Reguart N		0，，03：	1
11	Blockade of Wnt - 1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations 显示文摘	He B Reguart N You L	2005	Oncogene2005，24，18：	1
12	Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations显示文摘	REGUART N YOU L	2005	Oncogene2005，24，18：	1
13	Cloning and characterization of the promoter of human Wnt inhibitory factor-1显示文摘	Reguart N He B Xu Z D	2004	Biochem Biophys Res Commun2004，323，1：	1
14	Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine显示文摘	Vinolas N Provencio M Reguart N	2011	Lung Cancer2011，71，2：	1
15	Cloning and characterization of the promoter of human Wnt inhibitory factor-1显示文摘	HE B XU Z	2004	Biochem Biophys Res Commun2004，323，1：	1
16	Cloning and characterization of the promoter of human Wnt inhibitory factor-1显示文摘	He B Xu Z	2004	Biochem Biophys Res Commun2004，323，1：	1
17	Sleeve lobectomy after induction chemoradiotherapy显示文摘	G6mez-Caro A Boada M Reguart N	2012	EurJ Cardiothorac Surg2012，41，5：	1
18	Beyond EGFR TKI in EG FR-mutant non-small cell lung cancer patients: main challenges still to be overcome显示文摘	Remon J Mor6n T Reguart N	2014	Cancer Treat Rev2014，40，6：	1
19	Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations显示文摘	He B Reguart N You L	2005	Oncogene2005，24，18：	1
20	BRCAI:a new genomic marker for non-small-cell lung cancer显示文摘	Reguart N Cardona AF Carrasco E	2008	Clin Lung Cancer2008，9，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示